Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

Please provide your email address to receive an email when new articles are posted on . ROCHESTER, N.Y. — Bausch & Lomb plans to license processed human plasma from Bayer for use in ophthalmology, the ...

Team finds closed plasminogen conformation transiently exposes binding site. Scientists report the X-ray crystal structure of full-length human plasminogen, and describe binding of blood clots to ...

BIRMINGHAM, Ala. - Why is the COVID-19 virus more dangerous in people with comorbidities? Sadis Matalon, Ph.D., of the University of Alabama at Birmingham and colleagues in Texas and San Francisco ...

The global impact of the COVID-19 pandemic on healthcare systems has been significant. The sudden surge in infected cases overwhelmed hospitals and disrupted routine healthcare services, thus further ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the ...

A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week. Sadis Matalon, Ph.D., of ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the ...